Suppr超能文献

吡哆醇依赖型癫痫患者采用吡哆醇和精氨酸补充剂联合赖氨酸限制饮食的联合治疗:一项全面的系统评价。

Combination Therapy with Pyridoxine and Arginine Supplementations along with a Lysine-Restricted Diet in Individuals with Pyridoxine-Dependent Epilepsy: A Comprehensive Systematic Review.

作者信息

Jafari Ali, Abbasi Mohammad Mehdi, Abbasi Hamid, Rahnemayan Sama, Bakhshimoghaddam Farnush, Doaei Saeid

机构信息

Student Research Committee, Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Systematic Review and Meta-analysis Expert Group, Universal Scientific Education and Research Network, Tehran, Iran.

出版信息

Curr Dev Nutr. 2025 Jul 8;9(8):107504. doi: 10.1016/j.cdnut.2025.107504. eCollection 2025 Aug.

Abstract

BACKGROUND

Pyridoxine-dependent epilepsy (PDE) is identified as a rare neurometabolic disease marked by biallelic pathogenic mutations of the ALDH7A1 gene. A combination therapy involving pyridoxine, arginine supplementation (AS), and a lysine-restricted diet (LRD) was frequently reported to effectively improve PDE through reducing neurotoxic lysine metabolites, improving seizure management, and enhancing neurodevelopmental outcomes.

OBJECTIVES

The study sought to investigate the effects of mono-(pyridoxine), dual- (pyridoxine combined with AS or LRD), and triple-therapy approaches in individuals diagnosed with PDE.

METHODS

An extensive search was carried out across international databases, comprising Scopus, Embase, Web of Science, PubMed, and Google Scholar, to find relevant publications published before 12 November, 2024. The methodological quality assessment of chosen articles was evaluated utilizing the Newcastle-Ottawa Scale and the Joanna Briggs Institute tool.

RESULTS

Among 2097 studies reviewed, 38 met inclusion criteria, covering treatment methods for individuals with PDE including monotherapy (22 articles), dual therapy (9 articles), and triple therapy (7 articles). The results indicated that pyridoxine monotherapy is a highly effective first-line treatment in PDE that improves seizure control with minimal cognitive decline. Combining pyridoxine with an LRD or AS targets metabolic issues, reducing neurotoxic metabolites and enhancing cognitive and motor functions. Early triple therapy, within the first 6 months of life, exhibited significant benefits for seizure management and cognitive performance in patients with PDE.

CONCLUSIONS

In summary, administration of pyridoxine is highly effective, particularly when combined with AS and an LRD. Triple therapy illustrates promise for improved seizure control and cognitive function, especially when initiated early. Further research is warranted.

摘要

背景

吡哆醇依赖性癫痫(PDE)被认为是一种罕见的神经代谢疾病,其特征是ALDH7A1基因的双等位基因致病性突变。经常有报道称,一种联合治疗方法,包括补充吡哆醇、补充精氨酸(AS)和限制赖氨酸饮食(LRD),通过减少神经毒性赖氨酸代谢物、改善癫痫控制和提高神经发育结局,可有效改善PDE。

目的

本研究旨在调查单药治疗(吡哆醇)、双药治疗(吡哆醇联合AS或LRD)和三联治疗方法对诊断为PDE的个体的影响。

方法

在包括Scopus、Embase、科学网、PubMed和谷歌学术在内的国际数据库中进行了广泛搜索,以查找2024年11月12日前发表的相关出版物。使用纽卡斯尔-渥太华量表和乔安娜·布里格斯研究所工具对所选文章的方法学质量进行评估。

结果

在审查的2097项研究中,38项符合纳入标准,涵盖了PDE个体的治疗方法,包括单药治疗(22篇文章)、双药治疗(9篇文章)和三联治疗(7篇文章)。结果表明,吡哆醇单药治疗是PDE中一种非常有效的一线治疗方法,可在最小程度的认知下降情况下改善癫痫控制。将吡哆醇与LRD或AS联合使用可针对代谢问题,减少神经毒性代谢物,并增强认知和运动功能。在生命的前6个月内进行早期三联治疗,对PDE患者的癫痫管理和认知表现显示出显著益处。

结论

总之, 吡哆醇的给药非常有效,特别是与AS和LRD联合使用时。三联治疗显示出改善癫痫控制和认知功能的前景,尤其是早期开始治疗时。有必要进行进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验